Literature DB >> 9361846

Health benefits of non-digestible oligosaccharides.

M B Roberfroid1.   

Abstract

Non-digestible oligosaccharides are complex carbohydrates of the non-a-glucan type which, because of the configuration of their osidic bonds, resist hydrolysis by salivary and intestinal digestive enzymes. In the colon they are fermented by anaerobic bacteria. Among the non-digestible oligosaccharides, the chicory fructooligosaccharides occupy a key position and, in most european countries, they are recognised as natural food ingredients. The other major products are the short chain fructooligosaccharides and galactooligosaccharides obtained by enzymatic synthesis using sucrose and lactose as substrates respectively, the soybean oligosaccharides, the xylooligosaccharides produced by partial hydrolysis of xylans and polydextrose or pyrodextrins prepared by a chemical treatment of carbohydrates. The most well known effect of most non-digestible oligosaccharides, and in particular of the fructooligosaccharides, is the selective stimulation of the growth of Bifidobacteria thus modifying significantly the composition of the colonic microbiota. Such a modification, which has clearly been demonstrated in human volunteers, is meant to be benificial in part because it is accompanied by a significant reduction in the number of bacteria reported to have pathogenic potential. Within the framework of research and development of "functional foods", such an effect justifies a "functional claim" for fructooligosaccharides namely "bifidogenesis". They are also typical "prebiotics". Besides their bifidogenic effect, the chicory fructooligosaccharides have additional nutritional properties on digestive physiological parameters like colonic pH and stool bulking which justify their classification as dietary fibers. Moreover, in experimental models, it has also been reported that they improve the bioavailability of essentiel minerals and that they reduce serum triglyceridemia by lowering hepatic lipogenesis. Such effects demonstrate interactions between the chicory fructooligosaccharides and key functions in the body but their significance for humans still need to be proven before being used to justify additional claims.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361846     DOI: 10.1007/978-1-4615-5967-2_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  Molecular characterization of DSR-E, an alpha-1,2 linkage-synthesizing dextransucrase with two catalytic domains.

Authors:  Sophie Bozonnet; Marguerite Dols-Laffargue; Emeline Fabre; Sandra Pizzut; Magali Remaud-Simeon; Pierre Monsan; René-Marc Willemot
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

2.  Effect of synbiotics on intestinal microflora and digestive enzyme activities in rats.

Authors:  Suh-Ching Yang; Ju-Yen Chen; Huey-Fang Shang; Ting-Ying Cheng; Su Chen Tsou; Jiun-Rong Chen
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

3.  In vitro fermentation of prebiotics by Lactobacillus plantarum CFR 2194: selectivity, viability and effect of metabolites on β-glucuronidase activity.

Authors:  Madhu Arenahalli Ningegowda; Prapulla Siddalingaiya Gurudutt
Journal:  World J Microbiol Biotechnol       Date:  2011-09-23       Impact factor: 3.312

4.  Role of the two catalytic domains of DSR-E dextransucrase and their involvement in the formation of highly alpha-1,2 branched dextran.

Authors:  Emeline Fabre; Sophie Bozonnet; Audrey Arcache; René-Marc Willemot; Michel Vignon; Pierre Monsan; Magali Remaud-Simeon
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

5.  Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants.

Authors:  G Boehm; M Lidestri; P Casetta; J Jelinek; F Negretti; B Stahl; A Marini
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-05       Impact factor: 5.747

6.  Dietary Mannan Oligosaccharides Enhance the Non-Specific Immunity, Intestinal Health, and Resistance Capacity of Juvenile Blunt Snout Bream (Megalobrama amblycephala) Against Aeromonas hydrophila.

Authors:  Zhujin Ding; Xu Wang; Yunlong Liu; Yancui Zheng; Hongping Li; Minying Zhang; Yang He; Hanliang Cheng; Jianhe Xu; Xiangning Chen; Xiaoheng Zhao
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

Review 7.  Bladder and bowel dysfunction in Parkinson's disease.

Authors:  R Sakakibara; T Uchiyama; T Yamanishi; K Shirai; T Hattori
Journal:  J Neural Transm (Vienna)       Date:  2008-03-10       Impact factor: 3.575

8.  Bladder, bowel, and sexual dysfunction in Parkinson's disease.

Authors:  Ryuji Sakakibara; Masahiko Kishi; Emina Ogawa; Fuyuki Tateno; Tomoyuki Uchiyama; Tatsuya Yamamoto; Tomonori Yamanishi
Journal:  Parkinsons Dis       Date:  2011-09-12

9.  Effects of a soluble dietary fibre NUTRIOSE® on colonic fermentation and excretion rates in rats.

Authors:  Laetitia Guerin-Deremaux; Florence Ringard; Fabrice Desailly; Daniel Wils
Journal:  Nutr Res Pract       Date:  2010-12-28       Impact factor: 1.926

10.  Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers.

Authors:  Yoram Bouhnik; Lotfi Achour; Damien Paineau; Michel Riottot; Alain Attar; Francis Bornet
Journal:  Nutr J       Date:  2007-12-05       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.